discovery Archives -

The potential of monoclonal antibodies (mAbs) as therapies is indisputable. The current mAbs market is expected to be

Artificial Intelligence for better antibody drugs: ready for prime time?

https://pharmaphorum.com/views-and-analysis/artificial-intelligence-for-better-antibody-drugs-ready-for-prime-time/

Deliver Next Generation Degraders to Patients Faster

5th Annual Targeted Protein Degradation Summit

https://pharmaphorum.com/events/5th-annual-targeted-protein-degradation-summit/

Translate Neurodegenerative R&D Into the Clinic

9th Annual Neurodegenerative Drug Development Summit

https://pharmaphorum.com/events/9th-annual-neurodegenerative-drug-development-summit/

discovery